Dr. Shaji K. Kumar, MD

Dr. Kumar practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Kumar's NPI, 1568434090, was assigned on February 7, 2006. Dr. Kumar graduated from All India Institute of Medical Sciences in 1993. Dr. Kumar holds Minnesota license 41493.

Dr. Kumar's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Kumar's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Kumar to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Kumar is board certified in hematology by the American Board of Internal Medicine. Dr. Kumar is licensed in Minnesota.

Dmand AI lists anemia, multiple myeloma and neutropenia among the conditions Dr. Kumar treats.

CMS data shows 186 Medicare services from Dr. Kumar across 4 procedure codes in 2024, for 123 Medicare patients. Medicare paid $15,857 for them.

CMS counts 123 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 69 patients. 69% of them have high blood pressure, and 61% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 69, with 52% women.

In 2024, Dr. Kumar wrote 151 Medicare Part D claims for 59 patients. 77% of them were for generic drugs. CMS names the drug for 68 of them, across 4 drugs with 11 or more claims each, at $467,660 in total drug cost. In 2023, CMS named 72 claims across 3 drugs.

Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links 762 papers to Dr. Kumar, published from 2002 to 2025. 2020 was the busiest year, with 50. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Hematopoietic Stem Cell Transplantation. Dr. Kumar has published most often in Leukemia. Dr. Kumar's most frequent co-authors are Angela Dispenzieri, MD, Morie A. Gertz, MD and Sundararajan V. Rajkumar, MD.

Dmand AI links Dr. Kumar to 37 clinical trials, 14 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Amyloidosis. Mayo Clinic sponsors the most, 18. Open Payments lists research payments to Dr. Kumar that name 5 trials.

CMS Open Payments shows 353 general payments to Dr. Kumar from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Janssen Research & Development, LLC paid the most, $185,669. It also lists 68 research payments totaling $176,362 from 2016 to 2025, naming 5 clinical trials.

Dmand AI lists 7 awards for Dr. Kumar, most recently Merit Award in 2003.

Dr. Kumar graduated from All India Institute of Medical Sciences in 1993. Dr. Kumar is a member of ASH.

Dr. Kumar is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.